Browse Pet Safety Reports
970,550 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 970,550 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 970,550 FDA veterinary adverse event reports for Dog.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jun 13, 2026 | Dog | Shepherd Dog - German | Pyrantel Pamoate;Sarolaner | Blood in vomit; Death | Died |
| Jun 13, 2026 | Dog | Chihuahua | Fluralaner Powder For Inj Susp | Lack of efficacy (bacteria) - Borrelia; Lack of efficacy (bacteria) - Anaplasma | Ongoing |
| Jun 13, 2026 | Dog | Mountain Dog - Bernese | Fluralaner Powder For Inj Susp | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Jun 13, 2026 | Dog | Retriever - Golden | Bedinvetmab | Wobbliness; Collapse NOS (see also Cardio-vascular and Neurological disorders... | Outcome Unknown |
| Jun 13, 2026 | Dog | Retriever - Labrador, Dog (... | Desoxycortone | Behavioural disorder NOS | Recovered/Normal |
| Jun 13, 2026 | Dog | Crossbred Canine/dog | Moxidectin | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Jun 13, 2026 | Dog | Retriever - Labrador | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia; Lack of efficacy (ectoparasite) - tic... | Ongoing |
| Jun 13, 2026 | Dog | Terrier - Yorkshire | Atinvicitinib Oral Tablets | Lethargy (see also Central nervous system depression in Neurological); Anxiet... | Recovered/Normal |
| Jun 13, 2026 | Dog | Retriever - Labrador | Milbemycin Oxime; Praziquantel | Lack of efficacy (endoparasite) - roundworm NOS | Outcome Unknown |
| Jun 13, 2026 | Dog | Shepherd (unspecified), Dog... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Anaplasma; Medication error NOS | Ongoing |
| Jun 12, 2026 | Dog | Ridgeback - Rhodesian | Lotilaner,Moxidectin,Praziquantel,Pyr... | Vomiting; Sickness | Outcome Unknown |
| Jun 12, 2026 | Dog | Sheepdog - Shetland | Afoxolaner | Lack of efficacy (bacteria) - Anaplasma; Lack of efficacy (ectoparasite) - ti... | Ongoing |
| Jun 12, 2026 | Dog | Hound (unspecified), Dog (u... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Jun 12, 2026 | Dog | Shepherd Dog - German | Pyrantel Pamoate;Sarolaner | Vomiting | Recovered/Normal |
| Jun 12, 2026 | Dog | Maltese | Fluralaner Powder For Inj Susp | Not himself/herself; General pain (see other SOCs for specific pain); Letharg... | Ongoing |
| Jun 12, 2026 | Dog | Shepherd Dog - German | Oclacitinib Maleate | Vomiting; Lethargy (see also Central nervous system depression in Neurologica... | Ongoing |
| Jun 12, 2026 | Dog | Crossbred Canine/dog | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - hookworm | Outcome Unknown |
| Jun 12, 2026 | Dog | Shepherd Dog - Australian | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Jun 12, 2026 | Dog | Shepherd Dog - German | Nitenpyram | Vomiting; Listless; Diarrhoea; Decreased appetite; Lethargy (see also Central... | Outcome Unknown |
| Jun 12, 2026 | Dog | Retriever - Labrador | Moxidectin | Seizure NOS; Lethargy (see also Central nervous system depression in Neurolog... | Recovered/Normal |
| Jun 12, 2026 | Dog | Bulldog - American | Ilunocitinib | Injection site swelling; Ocular discharge | Recovered/Normal |
| Jun 12, 2026 | Dog | Retriever - Golden, Poodle ... | Pyrantel Pamoate;Sarolaner | Falling; Unconscious; Lethargy (see also Central nervous system depression in... | Recovered/Normal |
| Jun 12, 2026 | Dog | Crossbred Canine/dog | Fluralaner Powder For Inj Susp | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Jun 12, 2026 | Dog | Dog (unknown) | Milbemycin/Lufenuron Tablets | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Jun 12, 2026 | Dog | Collie - Border, Dog (unknown) | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Anaplasma; Intentional misuse | Ongoing |
| Jun 12, 2026 | Dog | Collie - Border | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Lack of efficacy (bacteria) - Anaplasma; Lack of efficacy (bacteria) - Borrelia | Outcome Unknown |
| Jun 12, 2026 | Dog | Crossbred Canine/dog | Orbiflox/Momet/Posaco Eardrops | Loss of hearing | Recovered with Sequela |
| Jun 12, 2026 | Dog | Crossbred Canine/dog, Chihu... | Fluralaner Powder For Inj Susp | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Jun 12, 2026 | Dog | Terrier - Bull - American Pit | Oclacitinib Maleate | Diarrhoea; Blood in faeces; Vomiting; Regurgitation | Outcome Unknown |
| Jun 12, 2026 | Dog | Beagle | Lotilaner | Diarrhoea; Product defect, product difficult to use/handle (see also 'Drug de... | Ongoing |
| Jun 12, 2026 | Dog | Crossbred Canine/dog, Pug | Fluralaner Powder For Inj Susp | Emesis (multiple); Elevated liver enzymes NOS; Anorexia; Abdominal pain; High... | Ongoing |
| Jun 12, 2026 | Dog | Collie - Border | Moxidectin | Vomiting; Hives (see also Skin) | Ongoing |
| Jun 12, 2026 | Dog | Retriever - Labrador | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Ehrlichia; Lack of efficacy (endoparasite) - lu... | Ongoing |
| Jun 12, 2026 | Dog | Terrier - Bull - American Pit | Bedinvetmab | Elevated serum alkaline phosphatase (ALP) | Outcome Unknown |
| Jun 12, 2026 | Dog | Crossbred Canine/dog | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Jun 12, 2026 | Dog | Collie - Border | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Jun 12, 2026 | Dog | Retriever - Labrador, Dog (... | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Lack of efficacy (bacteria) - Ehrlichia | Outcome Unknown |
| Jun 12, 2026 | Dog | Dachshund (unspecified) | Atinvicitinib Oral Tablets | Lack of efficacy - NOS | Ongoing |
| Jun 12, 2026 | Dog | Collie (unspecified), Dog (... | Bedinvetmab | Partial lack of efficacy | Ongoing |
| Jun 12, 2026 | Dog | Chihuahua | Ophytrium | Application site dry skin | Recovered/Normal |
| Jun 12, 2026 | Dog | Collie (unspecified) | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia | Ongoing |
| Jun 12, 2026 | Dog | Terrier - Bull - American Pit | Moxidectin | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Jun 12, 2026 | Dog | Retriever - Labrador | Bedinvetmab | Polyuria; Polydipsia | Ongoing |
| Jun 12, 2026 | Dog | Terrier - Boston | Lotilaner,Moxidectin,Praziquantel,Pyr... | Emesis (multiple); Diarrhoea | Ongoing |
| Jun 12, 2026 | Dog | Spaniel - King Charles Cava... | Afoxolaner 18.75Mg / Moxidectin 90Mcg... | Lack of efficacy (endoparasite) - tapeworm | Outcome Unknown |
| Jun 12, 2026 | Dog | Crossbred Canine/dog | Fluralaner 5.46% 1-Month Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Jun 12, 2026 | Dog | Pointing Dog - German Short... | Pyrantel Pamoate;Sarolaner | Grand mal seizure | Recovered/Normal |
| Jun 12, 2026 | Dog | Bulldog - French | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Jun 12, 2026 | Dog | Retriever - Labrador, Dog (... | Bedinvetmab | General illness; Lethargy (see also Central nervous system depression in Neur... | Died |
| Jun 12, 2026 | Dog | Terrier - Yorkshire | Trilostane | Distress; Panting; Not eating; Lethargy (see also Central nervous system depr... | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.